Starna Therapeutics
Clinical trials sponsored by Starna Therapeutics, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for leukemia patients who have run out of options Results expected Nov 2026 (estimated)
- New drug STR-P004 aims to tame immune attacks on kidneys Results expected Feb 2027 (estimated)
- Experimental drug aims to tame stubborn autoimmune diseases Results expected Jul 2027 (estimated)
-
Experimental drug aims to tame stubborn autoimmune diseases
Disease control Not yet recruitingThis early study tests an experimental drug called STR-P005 in people with autoimmune diseases that have come back or not improved with standard treatments. The drug is given through an IV in multiple doses. The main goal is to check safety and see how the body handles the drug. …
Sponsor: Starna Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug STR-P004 aims to tame immune attacks on kidneys
Disease control Not yet recruitingThis early study tests a new drug called STR-P004 in 9 adults with immune-mediated kidney diseases. The goal is to see if the drug is safe and how the body processes it. Participants receive up to 8 infusions over 28 days, with possible dose increases. This is not a cure; it aims…
Sponsor: Starna Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for leukemia patients who have run out of options
Disease control Not yet recruitingThis early study tests a new drug called STR-P004 in 11 adults with a type of leukemia (ALL) that has come back or not responded to standard treatments. The main goals are to check if the drug is safe, find the right dose, and see if it helps fight the cancer. Participants will r…
Sponsor: Starna Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC